International Journal of Stroke: Oral Anticoagulants and DOAC–Antiplatelet Therapy Are Associated with Increased Major Bleeding Risk
International Journal of Stroke shared a post on X about a recent article, by Sohei Yoshimura, published in SAGE Publishing, adding:
”Study finds oral anticoagulant alone and DOAC with antiplatelet therapy were associated with higher risks of major bleeding events than single antiplatelet therapy.”
Title: Long-term risk of bleeding events in patients taking antithrombotic agents for cerebrovascular or cardiovascular disease
Authors: Sohei Yoshimura, Kaori Miwa, Masatoshi Koga, Kanta Tanaka, Yoshiki Yagita, Yoshinari Nagakane, Haruhiko Hoshino, Tadashi Terasaki, Masayuki Shiozawa, Yasuyuki Iguchi, Shuji Arakawa, Shigeru Fujimoto, Yasushi Okada, Masafumi Ihara, Shinichi Takahashi, Ryosuke Doijiri, Makoto Sasaki, Yusuke Yakushiji, Teruyuki Hirano, Kazunori Toyoda
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention